Acute-graft-versus-host Disease
Showing 51 - 75 of >10,000
Grade B Acute GVHD, Grade C Acute GVHD, Grade D Acute GVHD Trial in United States (Remestemcel-L)
Completed
- Grade B Acute Graft Versus Host Disease
- +2 more
- Remestemcel-L
-
Los Angeles, California
- +19 more
Feb 18, 2022
Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)
Terminated
- Steroid-Refractory Acute Graft Versus Host Disease
-
Birmingham, Alabama
- +47 more
Jan 22, 2023
Acute GVHD Trial in United States (natalizumab, steroids)
Active, not recruiting
- Acute Graft Versus Host Disease
-
Duarte, California
- +11 more
Oct 15, 2021
Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using
Recruiting
- Relapsed Pediatric ALL
- +2 more
- In Vitro T cells depletion using CliniMCAS system
-
Shanghai, ChinaShanghai Children's Medical Center
Sep 28, 2022
GVHD, Acute Trial in Suzhou (autologous fecal bacteria)
Recruiting
- Graft Versus Host Disease, Acute
- autologous fecal bacteria
-
Suzhou, Jiangsu, ChinaYe Zhao
Aug 19, 2021
GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose
Terminated
- Graft Versus Host Disease
- Cyclophosphamide and Sirolimus
- +3 more
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022
Successful Cyclosporine Acute GVHD Prophylaxis in Children
Completed
- Acute-graft-versus-host Disease
-
Toronto, Ontario, CanadaHospital for Sick Children
Aug 12, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Biospecimen Collection
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2023
GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)
Recruiting
- GVHD,Acute
- GVHD, Chronic
- Physical exercise
-
Salamanca, SpainUniversity of Salamanca
May 27, 2022
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Active, not recruiting
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Jul 19, 2021
GVHD Trial in Minneapolis (Pregnyl®)
Active, not recruiting
- Graft vs Host Disease
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 3, 2022
GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))
Not yet recruiting
- Graft Versus Host Disease
- Allogeneic mesenchymal stromal cells (MSCs)
- Extracorporeal photopheresis (ECP)
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022
GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)
Completed
- Graft Versus Host Disease
- GVHD
- Panobinostat
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)
Recruiting
- Acute Myelogenous Leukemia
- +4 more
- Stem cell transplantation
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 23, 2022
Abatacept, Acute-graft-versus-host Disease, Haplo-identical HCT Trial in Suzhou (Lower dose of abatacept, Higher dose of
Recruiting
- Abatacept
- +3 more
- Lower dose of abatacept
- Higher dose of abatacept
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Jun 1, 2021
Acute-graft-versus-host Disease Trial in Worldwide (Alpha-1 antitrypsin (AAT), Placebo)
Recruiting
- Acute-graft-versus-host Disease
- Alpha-1 antitrypsin (AAT)
- Placebo
-
Scottsdale, Arizona
- +19 more
Sep 8, 2022
Graft Vs Host Disease Trial in United States (PRO 140)
Terminated
- Graft Vs Host Disease
- PRO 140
-
Miami, Florida
- +7 more
Jan 13, 2022
GVHD in GI Tract Trial in Graz (Fecal microbiota transplantation)
Recruiting
- Graft Versus Host Disease in GI Tract
- Fecal microbiota transplantation
-
Graz, Styria, AustriaDivision of Gastroenterology and Hepatology, Department of Inter
Apr 5, 2022
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)
Not yet recruiting
- GVHD
- Acute Stem Cell Transplant Complications
-
Chendu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 3, 2023
Analysis of Intestinal Defensin Expression in Acute GVHD
Active, not recruiting
- GVHD,Acute
- +2 more
-
Freiburg, Baden-Württemberg, GermanyMedical Center University of Freiburg
Nov 3, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Acute GVHD in Intestine Trial in Beijing, Jinan (Fecal Microbiota Transplantation, drug)
Recruiting
- Acute Graft Versus Host Disease in Intestine
- Fecal Microbiota Transplantation
- drug
-
Beijing, Beijing, China
- +1 more
Aug 30, 2021
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022